- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 21.08. | The Oral GLP-1 Tracker: Novo's Wegovy pill back on track as Lilly's momentum slows | ||
| 20.08. | Roche earmarks $750M to double the size of its Oregon manufacturing facility | ||
| 20.08. | Xspray's Dasynoc approval bid foiled again by FDA's manufacturer concerns | ||
| 20.08. | Aurinia settles with Teva, helping stave off potential Lupkynis generic until late 2036 | ||
| 20.08. | B. Braun recalls IV solution from US, Canada hospitals on particle contamination concerns | ||
| 20.08. | Lucid Group names leading Publicis Health exec as new CEO | ||
| 20.08. | Boehringer Ingelheim again rises up rare disease reputation rankings | ||
| 19.08. | SK strikes settlement with MSN over future Xcopri generic: reports | ||
| 19.08. | Contractor SK Pharmteco heralds completion of 2 API plants in Ireland | ||
| 19.08. | Aurobindo unit, China API maker dinged in latest round of FDA warning letters | ||
| 19.08. | Genetix kicks off sickle cell disease awareness campaign with NFL Alumni Association | ||
| 18.08. | Revance hires Janelle Wichmann as chief marketing officer of skincare unit | ||
| 18.08. | Pharma commercialization partner Valeris brings in new strategy chief | ||
| 18.08. | CSL shares up 17% as immunoglobulin boost points to signs of recovery | ||
| 18.08. | Biokin bispecific ADC iza-bren hits goal in lung cancer trial, boosting case for BMS' global test | ||
| 18.08. | CMI adopts orphan drug field with dedicated center of excellence | ||
| 18.08. | Celcuity keeps cool amid questions about Revtorpyk launch timing | ||
| 18.08. | Eurofins expands operations to meet growing high-potency API demand | ||
| 17.08. | EyePoint shares plummet after phase 3 stumble for AMD drug-device combo Duravyu | ||
| 17.08. | Quanovate takes back marketing claims for Mira fertility wand after P&G challenge | ||
| 17.08. | Sanofi to lay off 229 Blueprint Medicines staffers, close Cambridge offices following acquisition | ||
| 17.08. | Sandoz strikes $322M biosimilars deal with Shanghai Henlius | ||
| 17.08. | AstraZeneca touts Enhertu, Orpathys dual lung cancer wins amid bispecific failure | ||
| 17.08. | Argenx heads to FDA with Vyvgart after ph. 3 win in potential blockbuster autoimmune indication | ||
| 17.08. | Inside agency view: Real Chemistry's Frank Mazzola on audience nuance and rewarding creativity |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.